AMLX
Amylyx Pharmaceuticals Inc
NASDAQ: AMLX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$14.73
-3.09% today
Updated 2026-05-08
Market cap
$1.69B
P/E ratio
—
P/S ratio
0.66x
EPS (TTM)
$-1.48
Dividend yield
—
52W range
$4 – $19
Volume
1.1M
Amylyx Pharmaceuticals Inc (AMLX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-63.30%
ROA
-38.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $1.43M | $-14.82M | -734.43% | -950.49% | -1,038.99% |
| 2020 | $650000.00 | $-42.28M | -3,683.69% | -6,000.77% | -6,504.62% |
| 2021 | $285000.00 | $-87.88M | 100.00% | -29,013.33% | -30,834.74% |
| 2022 | $22.23M | $-198.38M | 86.54% | -905.72% | -892.38% |
| 2023 | $380.79M | $49.27M | 93.32% | 10.19% | 12.94% |
| 2024 | $87.37M | $-301.74M | 51.75% | -360.22% | -345.36% |
| 2025 | $0.00 | $-144.74M | — | — | — |